25 results
S-8
EX-4.2
VKTX
Viking Therapeutics Inc
22 May 24
Registration of securities for employees
4:33pm
) to exclude the effects of stock-based compensation and the award of bonuses under the Company’s bonus plans; (10) to exclude costs incurred in connection
424B5
VKTX
Viking Therapeutics Inc
1 Mar 24
Prospectus supplement for primary offering
4:13pm
into or exercisable for shares of our common stock in accordance with their terms, pursuant to any stock option, stock bonus, equity incentive or other stock plan
8-K
EX-1.1
VKTX
Viking Therapeutics Inc
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
Stock Plans described in the Time of Sale Prospectus; and the description of the Company’s stock option, stock bonus and other stock plans … of Common Stock in accordance with their terms, pursuant to any stock option, stock bonus, equity incentive or other stock plan or arrangement; provided
424B5
VKTX
Viking Therapeutics Inc
27 Feb 24
Prospectus supplement for primary offering
5:21pm
in accordance with their terms, pursuant to any stock option, stock bonus, equity incentive or other stock plan or arrangement; provided that the underlying
PRE 14A
b36sav6efrlbxn1hxm3
17 Apr 23
Preliminary proxy
5:04pm
8-K
EX-1.1
8qjithjk2 o67a83pqi
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm
8-K
t78s97ob
6 Jan 21
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
2aa0 lkaf
2 Aug 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
zy8wmauhhlyqrch7kql
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am